Published in Cancer Epidemiol Biomarkers Prev on March 17, 2009
Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res (2010) 1.44
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis. Am J Epidemiol (2011) 1.22
Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis. Cancer Prev Res (Phila) (2010) 1.11
Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07
Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors. Cancer Prev Res (Phila) (2010) 0.98
Nonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia. Cancer Epidemiol Biomarkers Prev (2011) 0.92
Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov (2011) 0.92
Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). Cancer Causes Control (2011) 0.89
Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control (2012) 0.86
Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study. J Thorac Oncol (2012) 0.85
Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control (2011) 0.82
Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice. Oncol Lett (2012) 0.79
Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention. Cancers (Basel) (2014) 0.79
Chemoprevention of lung cancer: prospects and disappointments in human clinical trials. Cancers (Basel) (2013) 0.78
Chemoprevention studies within lung cancer screening programmes. Ecancermedicalscience (2015) 0.78
Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study. Lung Cancer (2012) 0.77
Nonsteroidal Anti-Inflammatory Drug and Aspirin Use in Relation to Lung Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev (2015) 0.75
Association of stem-like cells in gender-specific chemoprevention against intestinal neoplasia in MIN mouse. Oncol Rep (2011) 0.75
Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis. PLoS One (2015) 0.75
Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure. J Biol Inorg Chem (2012) 0.75
VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol (2004) 3.97
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst (1993) 3.05
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep (2005) 2.96
Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med (2007) 2.55
Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Ann Thorac Surg (2006) 2.31
Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology (1996) 2.30
Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett (1999) 1.64
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. Subcell Biochem (2007) 1.63
Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer (2000) 1.44
Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit Rev Oncol Hematol (2008) 1.42
Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. Chest (2005) 1.30
Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist Updat (2004) 1.22
Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev (2008) 1.17
COX-2 inhibition and lung cancer. Semin Oncol (2004) 1.06
Celecoxib decreases Ki-67 proliferative index in active smokers. Clin Cancer Res (2006) 1.05
Association between nonsteroidal anti-inflammatory drug use and the incidence of lung cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev (2006) 0.98
Chemoprevention of lung cancer--from biology to clinical reality. Ann Oncol (2004) 0.92
17-Beta estradiol and hydroxyestradiols interact via the NF-kappa B pathway to elevate cyclooxygenase 2 expression and prostaglandin E2 secretion in human bronchial epithelial cells. Toxicol Sci (2008) 0.81
Expression and significance of cyclooxygenase 2 gene in lung cancer. J Huazhong Univ Sci Technolog Med Sci (2004) 0.79
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol (2013) 7.97
The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol (2003) 7.49
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med (2012) 6.77
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA (2003) 4.72
Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 4.15
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol (2004) 3.97
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med (2008) 3.60
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control (2002) 3.27
Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14
Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst (2013) 2.99
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units. Am J Respir Crit Care Med (2015) 2.86
Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst (2004) 2.84
Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA (2008) 2.73
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med (2007) 2.55
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res (2003) 2.49
Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol (2003) 2.38
Cardiovascular events associated with ipratropium bromide in COPD. Chest (2009) 2.36
Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol (2013) 2.26
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Penalizing hospitals for chronic obstructive pulmonary disease readmissions. Am J Respir Crit Care Med (2014) 2.08
Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev (2009) 2.00
Screening mammography: clinical image quality and the risk of interval breast cancer. AJR Am J Roentgenol (2002) 1.97
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Alcohol screening scores and medication nonadherence. Ann Intern Med (2008) 1.94
Buccal cell DNA yield, quality, and collection costs: comparison of methods for large-scale studies. Cancer Epidemiol Biomarkers Prev (2002) 1.92
A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med (2006) 1.91
A comprehensive examination of health conditions associated with obesity in older adults. Am J Prev Med (2004) 1.89
Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev (2004) 1.82
Yoga practice is associated with attenuated weight gain in healthy, middle-aged men and women. Altern Ther Health Med (2005) 1.79
Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med (2003) 1.77
Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr (2007) 1.76
Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol (2011) 1.71
A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care (2007) 1.69
Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev (2005) 1.69
Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol (2009) 1.63
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol (2009) 1.63
Risk factors for renal cell carcinoma in the VITAL study. J Urol (2013) 1.62
The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res (2011) 1.62
Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58
Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.53
Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol (2011) 1.52
Regional variation in health status among chronic obstructive pulmonary disease patients. Respiration (2010) 1.52
Effects of sustained audit/feedback on self-reported health status of primary care patients. Am J Med (2004) 1.52
The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest (2014) 1.51
Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest (2015) 1.49
Test-retest reliability of the Women's Health Initiative physical activity questionnaire. Med Sci Sports Exerc (2009) 1.48
Adult asthma disease management: an analysis of studies, approaches, outcomes, and methods. Respir Care (2009) 1.46
An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med (2010) 1.45
Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Arch Dermatol (2009) 1.44
Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality. Am J Epidemiol (2009) 1.42
Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.42
Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med (2005) 1.41
Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med (2012) 1.33
Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail (2012) 1.32
Poverty, obesity, and malnutrition: an international perspective recognizing the paradox. J Am Diet Assoc (2007) 1.32
Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms. AJR Am J Roentgenol (2002) 1.32
Assessment of a one-page questionnaire on long-term recreational physical activity. Epidemiology (2004) 1.32
Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol (2003) 1.31
Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control (2004) 1.30
Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol (2010) 1.30
Reliability and validity of 2 single-item measures of psychosocial stress. Epidemiology (2006) 1.30
Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr (2008) 1.26
Associations of psychosocial factors with fruit and vegetable intake among African-Americans. Public Health Nutr (2007) 1.26
Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2007) 1.25
Anthropometrics and prostate cancer risk. Am J Epidemiol (2007) 1.25
Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report. Am J Respir Crit Care Med (2012) 1.25
Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control (2007) 1.22
An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicine. Am J Respir Crit Care Med (2010) 1.20
Development and validation of the mindful eating questionnaire. J Am Diet Assoc (2009) 1.19
Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. Int J Cancer (2005) 1.19
Obesity, overweight, and weight control practices in U.S. veterans. Prev Med (2009) 1.18
Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.18
Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med (2004) 1.18
A novel custom resequencing array for dilated cardiomyopathy. Genet Med (2010) 1.18
Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.15
Total mortality risk in relation to use of less-common dietary supplements. Am J Clin Nutr (2010) 1.15
Postdiagnosis change in bodyweight and survival after breast cancer diagnosis. Epidemiology (2012) 1.14
Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study. Cancer Epidemiol Biomarkers Prev (2009) 1.14
Dietary supplement use and medical conditions: the VITAL study. Am J Prev Med (2003) 1.14
Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respir Med (2009) 1.13
Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.13
Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort. Gynecol Oncol (2012) 1.13